BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15082312)

  • 1. Telomerase RNA structure and function: implications for dyskeratosis congenita.
    Chen JL; Greider CW
    Trends Biochem Sci; 2004 Apr; 29(4):183-92. PubMed ID: 15082312
    [No Abstract]   [Full Text] [Related]  

  • 2. A telomerase component is defective in the human disease dyskeratosis congenita.
    Mitchell JR; Wood E; Collins K
    Nature; 1999 Dec; 402(6761):551-5. PubMed ID: 10591218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic behavior of the telomerase RNA hairpin structure and its relationship to dyskeratosis congenita.
    Yingling YG; Shapiro BA
    J Mol Biol; 2005 Apr; 348(1):27-42. PubMed ID: 15808851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting dyskeratosis.
    Meier UT
    Nat Genet; 2003 Feb; 33(2):116-7. PubMed ID: 12560816
    [No Abstract]   [Full Text] [Related]  

  • 5. An atypical form of dyskeratosis congenita with renal agenesis and no mutation in DKC1, TERC and TERT genes.
    Balci S; Engiz O; Erekul A; Gozdasoglu S; Vulliamy T
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):607-8. PubMed ID: 19415813
    [No Abstract]   [Full Text] [Related]  

  • 6. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.
    Marrone A; Dokal I
    Expert Rev Mol Med; 2004 Dec; 6(26):1-23. PubMed ID: 15613268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human genetics. Testing telomerase.
    Marciniak R; Guarente L
    Nature; 2001 Sep; 413(6854):370-1, 373. PubMed ID: 11574867
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and functional characterization of human telomerase RNA processing and cajal body localization signals.
    Theimer CA; Jády BE; Chim N; Richard P; Breece KE; Kiss T; Feigon J
    Mol Cell; 2007 Sep; 27(6):869-81. PubMed ID: 17889661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita mutations in dyskerin SUMOylation consensus sites lead to impaired telomerase RNA accumulation and telomere defects.
    Brault ME; Lauzon C; Autexier C
    Hum Mol Genet; 2013 Sep; 22(17):3498-507. PubMed ID: 23660516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification.
    Ruggero D; Grisendi S; Piazza F; Rego E; Mari F; Rao PH; Cordon-Cardo C; Pandolfi PP
    Science; 2003 Jan; 299(5604):259-62. PubMed ID: 12522253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells, telomerase and dyskeratosis congenita.
    Mason PJ
    Bioessays; 2003 Feb; 25(2):126-33. PubMed ID: 12539238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita mutations in the H/ACA domain of human telomerase RNA affect its assembly into a pre-RNP.
    Trahan C; Dragon F
    RNA; 2009 Feb; 15(2):235-43. PubMed ID: 19095616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita.
    Rashid R; Liang B; Baker DL; Youssef OA; He Y; Phipps K; Terns RM; Terns MP; Li H
    Mol Cell; 2006 Jan; 21(2):249-60. PubMed ID: 16427014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of dyskeratosis congenita mutations on the structure and dynamics of the human telomerase RNA pseudoknot domain.
    Yingling YG; Shapiro BA
    J Biomol Struct Dyn; 2007 Feb; 24(4):303-20. PubMed ID: 17206847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA.
    Theimer CA; Finger LD; Trantirek L; Feigon J
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):449-54. PubMed ID: 12525685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita and telomerase.
    Bessler M; Wilson DB; Mason PJ
    Curr Opin Pediatr; 2004 Feb; 16(1):23-8. PubMed ID: 14758110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.
    Machado-Pinilla R; Carrillo J; Manguan-Garcia C; Sastre L; Mentzer A; Gu BW; Mason PJ; Perona R
    Clin Transl Oncol; 2012 Oct; 14(10):755-63. PubMed ID: 22855157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations.
    Ashbridge B; Orte A; Yeoman JA; Kirwan M; Vulliamy T; Dokal I; Klenerman D; Balasubramanian S
    Biochemistry; 2009 Nov; 48(46):10858-65. PubMed ID: 19835419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.
    Zeng XL; Thumati NR; Fleisig HB; Hukezalie KR; Savage SA; Giri N; Alter BP; Wong JM
    Hum Mol Genet; 2012 Feb; 21(4):721-9. PubMed ID: 22058290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.